In conclusion, IL-18 is highly expressed in H1N1-induced severe lung injury in mice, and it is an appropriate cytokine to prime hUC-MSCs in vitro to improve precision therapy against viral-induced pneumonia, such as COVID-19. This evidence concerns the gene IL18 and COVID-19.